| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/21/2007 | EP1754487A1 Modulators of the Melted protein and uses thereof |
| 02/21/2007 | EP1754483A1 Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them |
| 02/21/2007 | EP1753861A2 Fructoseamine 3 kinase and the formation of collagen and elastin |
| 02/21/2007 | EP1753761A2 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof |
| 02/21/2007 | EP1753752A1 Highly selective novel amidation method |
| 02/21/2007 | EP1753743A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
| 02/21/2007 | EP1753736A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2007 | EP1753735A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| 02/21/2007 | EP1753733A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 02/21/2007 | EP1753730A1 Dipeptidyl peptidase inhibitors |
| 02/21/2007 | EP1753725A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 02/21/2007 | EP1753724A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 02/21/2007 | EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 02/21/2007 | EP1753714A2 2-substituted and 4-substituted aryl nitrone compouds |
| 02/21/2007 | EP1753443A1 Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition |
| 02/21/2007 | EP1753426A2 Ruminant treatments |
| 02/21/2007 | EP1753423A2 Benzoureas having anti-diabetic activity |
| 02/21/2007 | EP1608685B1 Vegf antagonists for the treatment of diabetes |
| 02/21/2007 | EP1608362B1 Stabilized pharmaceutical preparation comprising an amorphous active substance |
| 02/21/2007 | EP1529047B1 New purine derivatives |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 02/21/2007 | EP1414316B1 Nutritional composition preventing bacterial overgrowth |
| 02/21/2007 | EP1389466B1 A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1251847B1 Novel use of prodigiosin for treating diabetes mellitus |
| 02/21/2007 | EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 02/21/2007 | EP1104438B1 Novel anti-diabetic peptides |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918290A Screening method |
| 02/21/2007 | CN1918129A Therapeutic agent |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918121A Pyrrole-3-carboxamide derivatives for the treatment of obesity |
| 02/21/2007 | CN1918119A Bicycloester derivative |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917894A Muscular tension-elevating agent |
| 02/21/2007 | CN1917871A Methods and compositions for the treatment of lipodystrophy |
| 02/21/2007 | CN1916022A Gene correlative to cardiovascular pathology caused by diabetes, and usage |
| 02/21/2007 | CN1916014A Extractive of alfalfa, preparation method and usage |
| 02/21/2007 | CN1916012A Method for picking up and separating compound of flavone being as effective content of cinquefoil, and application |
| 02/21/2007 | CN1915992A Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/21/2007 | CN1915991A Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 02/21/2007 | CN1915986A High purified tanshinone óÄA sodium sulfonate, fabricating method, and preparation |
| 02/21/2007 | CN1915981A 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/21/2007 | CN1915399A Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method |
| 02/21/2007 | CN1915376A Slim tablet for person of to thinking to reduce weight |
| 02/21/2007 | CN1915352A Health product for reducing blood fat, and preparation method |
| 02/21/2007 | CN1915344A Nutrient for cell growth, preparation method, and application of finished product in treating tumor, cardiovascular and cerebrovascular diseases |
| 02/21/2007 | CN1915337A Capsule of eye protector for patient of diabetes |
| 02/21/2007 | CN1301323C Health beer and its preparation method |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/21/2007 | CN1301253C Pentatomic sulphur heterocyclic compound and its use for preparing medicine for treating preventing diseases related to adiposity |
| 02/21/2007 | CN1301109C Calcium, zinc and ferrum composite oral liquor and its preparing process |
| 02/21/2007 | CN1301096C Cordyceps drip pill used for nourishing lung and kidney and its preparation method |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179842 Method of treating non-insulin dependent diabetes mellitus with phytanic acid derivatives |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product |
| 02/20/2007 | US7179788 Synergistic mixtur eof glucangon-like peptide , in solid phase, and insulin solution, in liquid phase; antidiabetic agents; obesity |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179491 Contacting marine oil with an effective amount of a silica under a vacuum;contacting the oil with an effective amount of a bleaching clay;separating the silica from the oil; and separating the clay from the oil |
| 02/20/2007 | CA2422374C Purine derivatives |
| 02/20/2007 | CA2375225C Mutual salt of amlodipine and atorvastatin |
| 02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 02/20/2007 | CA2365078C Dietary compositions and methods |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2335520C Adenosine derivatives |
| 02/20/2007 | CA2151438C Thermostable trehalose-releasing enzyme, and its preparation and uses |
| 02/20/2007 | CA2128044C Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019416A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019346A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | WO2007019345A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | WO2007019344A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | WO2007019255A2 Salts of vildagliptin |
| 02/15/2007 | WO2007018460A1 Therapeutic agents |
| 02/15/2007 | WO2007018459A1 Therapeutic agents |
| 02/15/2007 | WO2007018314A2 Therapeutic agent for diabetes |
| 02/15/2007 | WO2007018281A1 Akt ACTIVATION INHIBITOR |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018193A1 Novel cercosporamide derivative |
| 02/15/2007 | WO2007017649A1 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 02/15/2007 | WO2007017505A2 Treatment of metabolic diseases |
| 02/15/2007 | WO2007017265A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017262A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017261A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017145A2 Gsk-3 inhibitors |
| 02/15/2007 | WO2007017124A1 Amorphous phase of a substituted pyrazoline, its preparation and use as medicament |